Ginkgo Bioworks Holdings, Inc. Logo

Ginkgo Bioworks Holdings, Inc.

A cell programming platform offering R&D services for pharma, agriculture, food, and chemicals.

DNA | US

Overview

Corporate Details

ISIN(s):
KYG8354H1267 (+2 more)
LEI:
Country:
United States of America
Address:
27 DRYDOCK AVENUE, 2210 BOSTON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Ginkgo Bioworks Holdings, Inc. is a synthetic biology company that operates a leading horizontal platform for cell programming. Its core mission is to make biology easier to engineer, enabling customers to program cells with the ease of programming computers. The company's platform leverages high-throughput automation, proprietary software, artificial intelligence, and an extensive biological codebase to design, build, and test custom organisms for its partners. Ginkgo provides flexible, end-to-end R&D services to solve challenges across diverse markets, including pharmaceuticals, agriculture, food and nutrition, and specialty chemicals, facilitating the development of novel and more sustainable products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ginkgo Bioworks Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ginkgo Bioworks Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ginkgo Bioworks Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CRONEX.CO.,LTD Logo
CRO supplying mini-pigs and bio-tissues for non-clinical R&D in medical and cosmetic industries.
South Korea
215570
C&R Research Inc. Logo
Leading South Korean CRO offering end-to-end clinical trial services for life science companies.
South Korea
359090
Cte Group Spolka Akcyjna Logo
Provides B2B services, corporate events, and advanced composite materials R&D.
Poland
LPS
curacle co., ltd. Logo
Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.
South Korea
365270
CytoMed Therapeutics Ltd Logo
Develops off-the-shelf cell immunotherapies using γδ T cells & NK cells for cancer treatment.
United States of America
GDTC
Cyxone AB Logo
Sweden
CYXO
DARWIN AG Logo
AI-powered biotech creating personalized health solutions from biological data for B2C & B2B.
Germany
7V0
DEINOVE Logo
France
ALDEI
Delta Drone Logo
Develops proprietary drone tech for logistics, security & military and consolidates the industry.
France
ALDR
Delta-Fly Pharma, Inc. Logo
Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.
Japan
4598

Talk to a Data Expert

Have a question? We'll get back to you promptly.